| Product |
CAS |
Molecular formula |
More |
| Oxazolidine, 2-(1-methoxyethenyl)-3-methyl-(9ci) |
748809-73-6 |
C7H13NO2 |
More |
| Piperazine, 1-[[4-(2-hydroxyethyl)-1-piperazinyl]acetyl]-4-(4-methoxyp |
604762-71-2 |
C19H30N4O3 |
More |
| Oxazolidine, 2-(1-methylethyl)-3-(2-propenyl)-(9ci) |
133920-08-8 |
C9H17NO |
More |
| Oxazolidine, 2-(1-methylethyl)-4-(2-methylpropyl)-, (4s)-(9ci) |
285124-27-8 |
C10H21NO |
More |
| Oxazolidine, 2-(methoxymethyl)-3,4,4-trimethyl-(9ci) |
752948-10-0 |
C8H17NO2 |
More |
| Oxazolidine, 2,2,5-trimethyl-4-(2-propenyl)-, (4r-trans)-(9ci) |
781579-91-7 |
C9H17NO |
More |
| Oxazolidine, 2,2-diethyl-4-(phenylmethyl)-, (4s)-(9ci) |
754962-92-0 |
C14H21NO |
More |
| Piperazine, 1-[2-(1-aziridinyl)ethyl]-(9ci) |
139341-07-4 |
C8H17N3 |
More |
| Oxazolidine, 2,3-diacetyl-2-methyl-(9ci) |
141916-15-6 |
C8H13NO3 |
More |
| Oxazolidine, 2,4,4-trimethyl-3-(2-propenyl)-(9ci) |
791746-39-9 |
C9H17NO |
More |
| Piperazine, 1-[2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl]- |
885689-10-1 |
C14H20N2O2 |
More |
| Oxazolidine, 2-ethyl-3-methyl-5-(phenoxymethyl)-(9ci) |
709601-81-0 |
C13H19NO2 |
More |
| Oxazolidine, 3-(aminoacetyl)-2,2-dimethyl-4-(1-methylethyl)-, (s)-(9ci |
770682-73-0 |
C10H20N2O2 |
More |
| Piperazine, 1-[2-(ethylthio)ethyl]-(7ci,8ci,9ci) |
702-07-8 |
C8H18N2S |
More |
| Piperazine, 1-[2-(formyloxy)-1-oxopropyl]-(9ci) |
131404-10-9 |
C8H14N2O3 |
More |
| Piperazine, 1-[2-(trimethylsilyl)ethyl]-(9ci) |
130596-57-5 |
C9H22N2Si |
More |
| Piperazine, 1-[2-fluoro-1-(fluoromethyl)ethyl]-(9ci) |
772330-41-3 |
C7H14F2N2 |
More |
| Oxazolidine, 3-(chloroacetyl)-4-(1-methylethyl)-, (s)-(9ci) |
102851-41-2 |
C8H14ClNO2 |
More |
| Piperazine, 1-[3-(4-methoxyphenyl)isothiazolo[4,5-d]pyrimidin-7-yl]-4- |
604741-42-6 |
C19H21N5O2S |
More |
| Piperazine, 1-[3-(4-fluorophenyl)isothiazolo[4,5-d]pyrimidin-7-yl]-4-( |
604741-36-8 |
|
More |
